Scotland retains neurosurgery network as foundation for new strategy
This article was originally published in Clinica
Scotland today announced that its four neurosurgery centres are to be retained as the basis of a strategy to modernise the service. Present arrangements for paediatric neurosurgery services, in particular, will be maintained at the Aberdeen, Dundee, Edinburgh and Glasgow centres, the Scottish Executive has highlighted. The decision is in line with the recommendations of the group set up in 2006 to advise the government on the development of a "managed service network". The Neuroscience Implementation Group is to remain active for an extra six months, with a view to developing a national service model.
You may also be interested in...
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.
Executives On The Move: Comings And Goings At Atara Biothera And Pfizer, Along With A Promotion At Domainex
T-cell immunotherapy firm Atara Biotherapeutics decides on a chief commercial officer and Pfizer oncology R&D head leaves for CSO spot at Vividion Therapeutics. Also, COO of UK drug discovery CRO Domainex is set to climb to CEO position.